Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 936K 867K 812K 1.52M 101M 1.53M 10.29M 3.99M 49.86M 4.03M 3.94M 173M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 721K 668K 625K 1.17M 78M 1.18M 7.92M 3.07M 38.39M 3.1M 3.04M 133M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
3 months+40.00%
6 months+600.00%
Current year+133.33%
Current year 0
Extreme 0.0004
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.03
5 years 0
Extreme 0
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 26/06/2019
Director TitleAgeSince
Director/Board Member 64 01/01/2003
Director/Board Member 84 01/01/2005
Director/Board Member - 01/03/2018
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+600.00%-97.48% 26.37K
-2.01%-6.58%-23.16%+9.94% 2,818B
-4.41%-7.97%-11.40%+782.35% 308B
+14.20%+21.57%+291.33%+872.43% 140B
-1.42%-2.74%+30.71%+69.03% 107B
+0.11%+0.59%-2.95%+7.26% 87.22B
-0.24%-4.45%+71.95%+135.68% 79.38B
-2.48%+3.29%-41.69%+50.46% 55.91B
+1.63%+12.54%+0.73%+72.37% 44.43B
-8.55%+4.75%-53.78%+22.20% 36.89B
Average -0.31%+5.06%+86.17%+192.42% 367.69B
Weighted average by Cap. -1.45%-1.13%-6.41%+113.32%

Financials

2015 2016
Net sales 4.22M 3.68M 3.41M 3.19M 5.99M 398M 6.02M 40.45M 15.68M 196M 15.85M 15.51M 681M 3.04M 2.65M 2.46M 2.3M 4.32M 287M 4.34M 29.17M 11.31M 141M 11.43M 11.18M 491M
Net income 151K 132K 122K 114K 214K 14.25M 215K 1.45M 561K 7.01M 567K 555K 24.35M -344K -300K -278K -260K -488K -32.46M -491K -3.3M -1.28M -15.98M -1.29M -1.26M -55.48M
Net Debt -340K -296K -275K -257K -482K -32.08M -485K -3.26M -1.26M -15.79M -1.28M -1.25M -54.83M -247K -215K -199K -187K -350K -23.31M -352K -2.37M -917K -11.47M -927K -907K -39.83M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
  1. Stock Market
  2. Stocks
  3. NMXS Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!